Gland Pharma’s net profit declines 15 percent; Shares hit 52-week low According to the company’s statement, its margin on earnings before interest, taxes, depreciation, and amortisation slipped to 35 percent from… January 24, 2023 12:32 IST
Gland Pharma shares fall 4% on Cenexi acquisition report; should you buy, hold or sell? Gland Pharma’s Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development… November 30, 2022 12:11 IST
Gland Pharma share price tanks 12% to hit 52-week low on weak Q1 results; stock may top Rs 3000 to rally 24% At least two research and brokerage firms — Motilal Oswal Financial Services and YES Securities are bullish on Gland Pharma… Updated: July 21, 2022 16:01 IST
Investor – Gland Pharma: Maintain ‘buy’; margins to be steady Gland has a relatively limited launched portfolio in the Rest-of-World Market and India, which will expand to provide growth opportunities. March 29, 2022 01:30 IST
